secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0000816956-26-000051
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q1 2026: GAAP EPS $0.45, adjusted EPS $0.89; raises FY organic revenue growth guidance
--------------------------------------------------------------------------------

- Sales $317.0M (-1.3% YoY); domestic -5.8%, international +4.7% as reported.
- GAAP EPS $0.45 vs $0.19 YoY; adjusted EPS $0.89 vs $0.95.
- FY 2026 organic constant currency revenue growth guidance raised to 5.0-6.5% from 4.5-6.0%.
- Reported revenue guidance raised to $1.350-1.375B; adjusted EPS reaffirmed $4.30-$4.45.
- GI product exit impacted sales by $15.5M; company focusing on higher-growth areas.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000051/0000816956-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000051/cnmd-20260429.htm
  HTML page:      https://secwatch.observer/filing/0000816956-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer